Clin2
NCT05988632Possibly a fitRecruiting

Insulin nasal spray for alcohol use disorder

Alcohol Use Disorder

Part of Mental health clinical trials.

This trial tests whether a nasal spray with insulin can help people with alcohol use disorder. It may affect how the brain responds to alcohol and reduce drinking.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1/Phase 2
Enrollment
40 people
Ages
21 years and older
Study type
Interventional

Who can take part

  • You are 21 years or older.
  • You have been diagnosed with alcohol use disorder (any severity).
  • In the past month, you drank at least as much as 2 drinks in one sitting.
  • You are generally healthy, based on medical history and tests.
  • You are willing to have your blood sugar checked with a finger stick during study visits.
  • You must not be pregnant or breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07520292Recruiting· Phase 1
Testing NTX-2001 to reduce drinking in alcohol use disorder

This study tests whether a new medication called NTX-2001 can help people with alcohol use disorder drink less. Researchers will measure how the drug affects alcohol consumption and safety in adults aged 21–60.

New Haven, Connecticut
NCT05929677Recruiting· Early Phase 1
Study tests effects on impulsivity and how alcohol feels

This early-phase study looks at how alcohol affects impulsivity (tendency to act quickly) and people’s subjective experiences. You may be able to join if you drink regularly and meet the study safety rules.

Boston, Massachusetts
NCT05957159Recruiting· Early Phase 1
Testing an alcohol brain imaging study based on opioid receptor balance

This early-phase study looks at how the brain’s opioid receptor balance may be different in people with alcohol use disorder (AUD), using brain scans and blood testing. It may help researchers understand why some people respond differently to alcohol and related treatments.

New Haven, Connecticut
NCT06489782Recruiting
New approach to test alcohol use disorder medications

This study tests a new way to quickly screen medications for alcohol use disorder (AUD). You will have lab sessions where your drinking is monitored to see how different medicines affect your alcohol use.

New Haven, Connecticut
NCT07249554Not yet recruiting· Phase 2
Combination therapy for alcohol use disorder

This trial tests two medicines — semaglutide and naltrexone — taken together to help reduce alcohol cravings and drinking. It aims to see if this combination is more effective than standard treatment for alcohol use disorder.

Havre de Grace, Maryland
NCT04084860Recruiting· Phase 2
Brief medicine trial to help reduce heavy alcohol drinking

This Phase 2 study tests a brief medication approach meant to reduce “problem drinking.” It may help people cut back or stop alcohol use by adjusting brain signaling related to drinking cravings and urges.

New York, New York

Hear when a new Alcohol Use Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.